- Global Pharma News & Resources

Lab Automation Market Overview 2023 to 2033 | By Component Type, Application, End User & Region

During the forecast period, the Lab Automation Market Demand is expected to develop at a CAGR of 10.1%. The market is predicted to grow from 2.1 billion US$ in 2023 to 5.5 billion US$ by 2033.

Research and Innovations Aid Market Growth

Consistent demand for pharmaceutical research holds the market together. Furthermore, automation is becoming more prevalent in the pharmaceutical and healthcare industries. Both of these are advantageous to the market, especially in developing countries. Furthermore, key players are interested in developing industry-specific products that address the needs of certain Lab Automation users.

For Details on Vendors and Their Offerings – Request A Sample Report@

Fertile Ground for Market Growth

Key businesses must spend more on product development to stay up with the quick rate of product acceptance. Because of variables such as improving diagnostic rates, this year is predicted to be beneficial for global market expansion. Current trends show that significant competitors are merging resources to strengthen their market positions through mergers and acquisitions.

Technological Innovations Emerge as an Integral Part of Market Growth

End-user demand for high-end, advanced Lab Automation technology is projected to drive long-term Lab Automation market prospects. Advances in lab robotics technology, which is still in its early stages, are expected to drive market growth. Lab Automation solutions must be exceptionally frictionless and efficient in order to attract pharmaceutical and healthcare enterprises of all sizes.

Can Market Key Players Rise Above the Hurdles of High Cost?

Lab Automation system adoption and maintenance are currently costly. As a result, small and medium-sized firms are wary about implementing laboratory automation technologies. The primary consumer base of key players is currently comprised of mega-corporations willing to spend millions on high-end efficient Lab Automation systems. By offering low-cost products, key companies can readily access the small and medium-sized business category. When the major organisation category reaches saturation, key players will be obliged to migrate to smaller firms in order to maintain market growth.

Ask More About This Market’s Geographical Distribution Along With a Detailed Analysis of the Top Regions@

Recent Market Developments:

  • Beckman Coulter Life Sciences will launch the CellMek SPS in March 2022. The product allows for easy manual sample preparation. It has contributed to the reduction of data management bottlenecks in clinical flow cytometry. It is a completely automated sample preparation system (SPS) that would help laboratories greatly increase their existing production capacities.
  • Strateos Inc. released an integrated system for small molecule discovery programmes that aid in automating the DMTA cycles in April 2022.
  • Biosero will deliver the Green Button Go software bundle in March 2022. It includes additional capabilities to help users have better control over laboratory systems.
  • In March 2022, Thermo Fisher Scientific and Hamilton Company jointly launched an advanced product. It is their forensic laboratory-qualified automated nucleic acid extraction platform.

Key Market Players:

  • Abbott Laboratories
  • Agilent Technologies
  • Perkin Elmer, Inc
  • Thermo Fisher Scientific, Inc
  • Siemens Healthcare
  • Danaher Corporation
  • Becton
  • Dickinson and Company
  • Transcriptic, Inc.

Buy Now to Gain Access to Detailed Information About Each Segment and Identify Key Trends, Drivers, and Challenges in the Market@

Key Segments

By Component Type:

  • Devices
    • Biochemistry Devices
    • Molecular Devices
    • Hematology Devices
    • Immunology Devices
    • Microbiology Devices
    • Others
  • Software
    • Scheduling Software
    • Momentum Integration Software

By Application:

  • Life Sciences Research and Development
  • Drug Discovery
  • Diagnostics

By End User:

  • Pharmaceutical Companies
  • Hospitals and Diagnostic Centers
  • Educational Institutions
  • Contract Research Organizations (CROs)
  • Research Institutes

About Future Market Insights, Inc.

Future Market Insights, Inc. (ESOMAR certified, Stevie Award – recipient market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.


Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries:
Browse All Reports:

Editor Details

Last Updated: 18-May-2023